The fourth quarter and full-year 2024 financial results press release will be issued before the market opens on April 4 th.

Good afternoon and welcome to Journey Medical's 2024 Financial Results and Corporate Update Conference Call (Operator Instructions) I would now like to turn the call over to Jaclyn Jaffe, the ...

Q4 2024 Earnings Call Transcript March 26, 2025 Journey Medical Corporation beats earnings expectations. Reported EPS is ...

On March 27, 2025, Vivani announced an $8.25 million equity financing which secures solid financial position into the second ...

The Weill Family Foundation is giving $50 million to enable 4 leading research institutions to form the Weill Cancer Hub East ...

Atrial fibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that its ...

The plaintiff in Lucuta v. Stevens, 2025 ONSC 1576 had a knee injury. In 2010, two doctors treated her for this injury at ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

Researchers at Boston-based Mass General Brigham and MIT have developed a long-acting contraceptive injection designed to be delivered through tiny needles, reducing discomfort and increasing ...

Chapter 2 this fall. As anticipation builds, we take a look at the box office performance of the first film in the franchise.

FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...